Yasuhiro Hasegawa Selected Research

Yasuhiro Hasegawa Research Topics

Disease

53	Stroke (Strokes) 06/2022 - 01/2004
24	Ischemic Stroke 12/2020 - 09/2007
14	Cerebral Hemorrhage 01/2021 - 09/2009
10	Atrial Fibrillation 07/2019 - 01/2011
9	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2018 - 04/2010
7	Neoplasms (Cancer) 01/2022 - 09/2014
7	Disease Progression 01/2021 - 03/2002
6	Pathologic Constriction (Stenosis) 08/2022 - 11/2009
6	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2008
6	Hemorrhage 11/2018 - 03/2014
5	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 12/2022 - 01/2013
4	Hyperplasia 08/2022 - 05/2019
4	Inflammation (Inflammations) 01/2022 - 09/2013
4	Infarction (Infarctions) 11/2021 - 08/2015
4	Hematoma 01/2021 - 12/2012
4	Embolism (Embolus) 01/2020 - 01/2016
4	Brain Infarction 04/2019 - 01/2003
4	Pain (Aches) 04/2019 - 03/2002
4	Transient Ischemic Attack 01/2019 - 08/2015
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 10/2017
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 04/2011
3	Acute Coronary Syndrome 01/2020 - 01/2012
3	Hyperglycemia 12/2019 - 11/2009
3	Migraine Disorders (Migraine) 09/2019 - 09/2013
3	Spinal Cord Diseases 01/2019 - 01/2014
3	Hypertension (High Blood Pressure) 01/2018 - 01/2011
3	Infections 01/2018 - 05/2007
3	Heart Failure 11/2009 - 09/2004
2	Dementia (Dementias) 01/2022 - 09/2019
2	Lymphadenopathy 01/2022 - 01/2016
2	Fever (Fevers) 01/2021 - 12/2020
2	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 01/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2020
2	Consciousness Disorders 12/2020 - 01/2014
2	Multiple Sclerosis 12/2020 - 07/2016
2	Dysarthria (Spastic Dysarthria) 08/2020 - 12/2017
2	Hypoglycemia (Reactive Hypoglycemia) 07/2020 - 12/2019
2	Hypoxia (Hypoxemia) 01/2020 - 10/2004
2	Anemia 01/2020 - 04/2011
2	Headache (Headaches) 09/2019 - 01/2014
2	Paresis (Hemiparesis) 04/2019 - 01/2014
2	Rheumatoid Arthritis 04/2019 - 10/2017
2	Biliary Atresia 03/2019 - 01/2018
2	Seizures (Absence Seizure) 01/2019 - 01/2014
2	Cerebral Infarction 11/2018 - 03/2018
2	Body Weight (Weight, Body) 01/2018 - 11/2014
2	Demyelinating Diseases (Demyelinating Disease) 12/2017 - 01/2010
2	Embolic Stroke 02/2017 - 11/2006
2	MELAS Syndrome (Syndrome, MELAS) 01/2016 - 01/2014
2	Ischemia 01/2016 - 08/2015
2	Atrophy 01/2016 - 03/2004
2	Thromboembolism 12/2015 - 01/2012
2	Colorectal Neoplasms (Colorectal Cancer) 04/2015 - 09/2014
2	Fibrosis (Cirrhosis) 12/2012 - 05/2007

Drug/Important Bio-Agent (IBA)

21	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2020 - 01/2009
9	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 09/2009
9	Warfarin (Coumadin)FDA LinkGeneric 07/2019 - 01/2012
9	AnticoagulantsIBA 07/2019 - 01/2012
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
7	SteroidsIBA 01/2021 - 01/2014
5	Vitamin K FDA Link 04/2016 - 01/2015
4	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022 - 10/2017
4	C-Reactive ProteinIBA 01/2022 - 04/2013
4	Blood Glucose (Blood Sugar)IBA 07/2020 - 01/2009
4	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 01/2011
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012 - 04/2010
3	fibrin fragment D (D-dimer)IBA 06/2022 - 12/2020
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2011
3	Indicators and Reagents (Reagents)IBA 10/2019 - 06/2004
3	Methylprednisolone FDA LinkGeneric 06/2019 - 01/2013
3	3-Iodobenzylguanidine (Iobenguane)IBA 11/2018 - 01/2008
3	Nicardipine (Dagan)FDA LinkGeneric 01/2018 - 12/2012
3	Pharmaceutical PreparationsIBA 12/2017 - 09/2014
3	Dabigatran FDA Link 04/2016 - 09/2015
3	LipidsIBA 01/2012 - 01/2011
2	AutoantibodiesIBA 01/2022 - 01/2022
2	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2021 - 02/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2016
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 10/2017
2	AcidsIBA 01/2021 - 01/2019
2	Immunoglobulins (Immunoglobulin)IBA 10/2020 - 01/2016
2	Member 11 Subfamily B ATP Binding Cassette TransporterIBA 06/2020 - 07/2014
2	NeopterinIBA 01/2020 - 01/2013
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019 - 01/2014
2	ChemokinesIBA 01/2019 - 09/2013
2	mogamulizumabIBA 01/2018 - 01/2015
2	N(4)-oleylcytosine arabinosideIBA 04/2016 - 01/2015
2	apixabanIBA 01/2016 - 09/2015
2	DiureticsIBA 09/2013 - 02/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2013 - 10/2004

Therapy/Procedure

41	Therapeutics 12/2022 - 04/2006
5	Stents 08/2022 - 04/2017
5	Secondary Prevention 01/2018 - 08/2005
4	Thrombolytic Therapy 11/2018 - 05/2013
3	Carotid Endarterectomy 08/2022 - 01/2020
3	Thrombectomy 01/2021 - 07/2018
2	Gastrectomy 01/2022 - 04/2011
2	Punctures 10/2019 - 04/2019
2	Plasmapheresis 01/2019 - 01/2003
2	Renal Dialysis (Hemodialysis) 11/2018 - 01/2015